Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free OTLC Stock Alerts

Oncotelic Therapeutics (OTLC) Short Interest Ratio & Short Volume

Oncotelic Therapeutics logo
$0.04 +0.00 (+1.60%)
As of 05/5/2026 03:53 PM Eastern
Compare

Oncotelic Therapeutics Short Interest Overview

As of April 15, 2026, Oncotelic Therapeutics (OTLC) had a short interest of 16 shares sold short, representing 0.00% of the public float. This marks a -99.90% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.0, meaning it would take 0.0 days of the average trading volume of 243,690 shares to cover all short positions.

Current Short Interest
16 shares
Previous Short Interest
15,516 shares
Change Vs. Previous Month
-99.90%
Dollar Volume Sold Short
$0.54
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
443,480,000 shares
Short Percent of Float
0.00%
Today's Trading Volume
62,998 shares
Average Trading Volume
243,690 shares
Today's Volume Vs. Average
26%
Short Selling Oncotelic Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Oncotelic Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

OTLC Short Interest Over Time

OTLC Days to Cover Over Time

OTLC Percentage of Float Shorted Over Time

Oncotelic Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202616 shares $0.54 -99.9%0.0%0 $0.03
3/31/202615,516 shares $615.99 +114.4%0.0%0.02 $0.04
3/13/20267,237 shares $235.93 -86.6%0.0%0.01 $0.03
2/27/202653,938 shares $2.50 thousand -65.7%0.0%0.12 $0.05
2/13/2026157,037 shares $7.38 thousand +959.3%0.1%0.14 $0.05
1/30/202614,825 shares $1.14 thousand 0.0%0.0%0.07 $0.08
1/15/202614,829 shares $1.04 thousand -0.4%0.0%0.04 $0.07
12/31/202514,881 shares $1.15 thousand -69.2%0.0%0.07 $0.08
12/15/202548,369 shares $4.32 thousand +5.2%0.0%0.18 $0.09
11/28/202545,995 shares $4.47 thousand +29.7%0.0%0.08 $0.10
11/14/202535,460 shares $3.03 thousand -83.4%0.0%0.07 $0.09
10/31/2025213,153 shares $20.68 thousand +74.3%0.1%0.45 $0.10
10/15/2025122,300 shares $12.23 thousand +122,200.0%0.0%0.1 $0.10
9/30/2025100 shares $7.70 -99.1%N/A0 $0.08
9/15/202510,600 shares $530.00 -65.6%N/A0.1 $0.05
8/31/202530,800 shares $1.64 thousand -59.6%0.0%0.2 $0.05
8/15/202576,200 shares $3.87 thousand -8.4%N/A0.6 $0.05
7/31/202583,200 shares $4.29 thousand +2,583.9%0.0%0.4 $0.05
7/15/20253,100 shares $179.80 -89.5%N/A0 $0.06
6/30/202529,600 shares $1.31 thousand -35.7%0.0%0.2 $0.04
6/15/202546,000 shares $2.27 thousand +84.7%0.0%0.5 $0.05
5/31/202524,900 shares $1.62 thousand -59.5%0.0%0.5 $0.07
5/15/202561,500 shares $3.39 thousand +13.3%0.0%1.2 $0.06
4/30/202554,300 shares $2.91 thousand -13.5%N/A0.4 $0.05
4/15/202562,800 shares $3.23 thousand +307.8%0.0%0.2 $0.05
3/31/202515,400 shares $1.00 thousand -44.0%0.0%0.1 $0.07
3/15/202527,500 shares $1.28 thousand -57.0%0.0%0.1 $0.05
2/28/202563,900 shares $2.52 thousand +15,875.0%0.0%0.4 $0.04
2/15/2025400 shares $15.96 -77.8%0.0%0 $0.04
1/31/20251,800 shares $54.54 +350.0%N/A0 $0.03
1/15/2025400 shares $13.76 -95.4%N/A0 $0.03
12/31/20248,600 shares $301.00 +230.8%N/A0 $0.04
12/15/20242,600 shares $78.00 +18.2%N/A0 $0.03
11/30/20242,200 shares $70.18 -94.9%N/A0 $0.03
11/15/202443,400 shares $1.30 thousand +137.2%N/A0.1 $0.03
10/31/202418,300 shares $590.18 -62.1%N/A0 $0.03
10/15/202448,300 shares $1.72 thousand +11,975.0%N/A0 $0.04
9/30/2024400 shares $8.40 -80.0%N/A0 $0.02
9/15/20242,000 shares $42.40 -59.2%N/A0 $0.02
8/31/20244,900 shares $111.23 +1,125.0%N/A0 $0.02
8/15/2024400 shares $8.24 No ChangeN/A0 $0.02
7/31/2024400 shares $11.20 -98.2%N/A0 $0.03
7/15/202422,000 shares $572.00 +266.7%N/A0.1 $0.03
6/30/20246,000 shares $195.00 +1,400.0%N/A0 $0.03
6/15/2024400 shares $15.72 -83.3%N/A0 $0.04
5/31/20242,400 shares $89.04 +500.0%N/A0 $0.04
5/15/2024400 shares $14.40 -77.8%N/A0 $0.04
4/30/20241,800 shares $71.91 -84.2%N/A0 $0.04
4/15/202411,400 shares $468.54 +2,750.0%N/A0.1 $0.04
3/31/2024400 shares $14.39 -89.7%N/A0 $0.04
3/15/20243,900 shares $144.69 -75.2%N/A0.1 $0.04
2/29/202415,700 shares $554.21 -90.9%N/A0.1 $0.04
2/15/2024172,400 shares $6.64 thousand +34.8%N/A0.9 $0.04
1/15/2024111,900 shares $4.42 thousand +27,875.0%N/A1.2 $0.04
12/31/2023400 shares $15.30 No ChangeN/A0 $0.04
12/15/2023400 shares $15.76 No ChangeN/A0 $0.04
11/30/2023400 shares $16.28 -97.6%N/A0 $0.04
11/15/202316,700 shares $542.75 -58.2%N/A0 $0.03
10/31/202339,900 shares $1.31 thousand +66.3%N/A0.1 $0.03
10/15/202324,000 shares $816.00 +1,400.0%N/A0.1 $0.03
9/30/20231,600 shares $49.60 -95.4%N/A0 $0.03
9/15/202334,500 shares $1.09 thousand -52.7%N/A0.1 $0.03
8/31/202372,900 shares $1.91 thousand +138.2%N/A0.2 $0.03
8/15/202330,600 shares $703.80 -4.7%N/A0.3 $0.02
7/31/202332,100 shares $767.19 -50.3%N/A0.1 $0.02
7/15/202364,600 shares $1.63 thousand +12.0%N/A0.1 $0.03
6/30/202357,700 shares $1.44 thousand +1,054.0%N/A0 $0.03
6/15/20235,000 shares $150.00 -79.8%N/A0 $0.03
5/31/202324,700 shares $768.17 +6,075.0%N/A0.1 $0.03
5/15/2023400 shares $14.76 -55.6%N/A0 $0.04
4/30/2023900 shares $37.80 +125.0%N/A0 $0.04
4/15/2023400 shares $20.40 -99.1%N/A0 $0.05
3/31/202342,900 shares $2.04 thousand +164.8%N/A0.3 $0.05
3/15/202316,200 shares $920.16 No ChangeN/A0.1 $0.06
2/28/202316,200 shares $891.00 -57.7%N/A0.1 $0.06
2/15/202338,300 shares $2.11 thousand +137.9%N/A0.1 $0.06
1/31/202316,100 shares $821.10 -68.2%N/A0.1 $0.05
1/15/202350,700 shares $2.94 thousand +53.6%N/A0.2 $0.06
12/30/202233,000 shares $1.49 thousand +11.9%N/A0.1 $0.05
12/15/202229,500 shares $1.42 thousand +2,358.3%N/A0.1 $0.05
11/30/20221,200 shares $70.32 -86.8%N/A0 $0.06
11/15/20229,100 shares $682.50 -65.5%N/A0.1 $0.08
10/31/202226,400 shares $1.19 thousand -58.8%N/A0 $0.05
10/15/202264,000 shares $3.74 thousand -49.7%N/A0.2 $0.06
9/30/2022127,200 shares $8.52 thousand +4,286.2%N/A0.3 $0.07
9/15/20222,900 shares $205.90 -62.8%N/A0 $0.07
8/31/20227,800 shares $630.24 -77.5%N/A0 $0.08
8/15/202234,600 shares $2.90 thousand -51.1%N/A0.1 $0.08
7/31/202270,700 shares $7.78 thousand +288.5%N/A0.2 $0.11
7/15/202218,200 shares $1.82 thousand -33.3%N/A0 $0.10
6/30/202227,300 shares $4.64 thousand +320.0%N/A0 $0.17
6/15/20226,500 shares $812.50 +14.0%N/A0 $0.13
5/31/20225,700 shares $1.23 thousand +119.2%N/A0 $0.22
5/15/20222,600 shares $507.00 -69.8%N/A0 $0.20
4/30/20228,600 shares $1.86 thousand +65.4%N/A0 $0.22
4/15/20225,200 shares $1.20 thousand +13.0%N/A0 $0.23
3/31/20224,600 shares $1.05 thousand -41.0%N/A0 $0.23
3/15/20227,800 shares $1.70 thousand -71.6%N/A0 $0.22
2/28/202227,500 shares $6.82 thousand +97.8%N/A0.1 $0.25
2/15/202213,900 shares $2.78 thousand +157.4%N/A0.1 $0.20
1/31/20225,400 shares $864.00 +1,250.0%N/A0 $0.16
1/15/2022400 shares $70.50 -95.1%N/A0 $0.18
12/31/20218,100 shares $1.36 thousand -30.2%N/A0 $0.17
12/15/202111,600 shares $1.91 thousand -80.3%N/A0 $0.17
11/30/202158,800 shares $7.94 thousand +429.7%N/A0.1 $0.14
11/15/202111,100 shares $1.28 thousand -74.5%N/A0 $0.12
10/29/202143,500 shares $5.66 thousand +42.6%N/A0.2 $0.13
10/15/202130,500 shares $3.58 thousand +682.1%N/A0.1 $0.12
9/30/20213,900 shares $565.50 -51.3%N/A0 $0.15
9/15/20218,000 shares $1.05 thousand +90.5%N/A0 $0.13
8/31/20214,200 shares $579.60 +2.4%N/A0 $0.14
8/13/20214,100 shares $512.50 -86.2%N/A0 $0.13
7/30/202129,800 shares $4.62 thousand +684.2%N/A0.1 $0.16
7/15/20213,800 shares $672.60 -83.0%N/A0 $0.18
6/30/202122,300 shares $0.00 +214.1%N/A0.1 $0.00

OTLC Short Interest - Frequently Asked Questions

What is Oncotelic Therapeutics' current short interest?

Short interest is the volume of Oncotelic Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 16 shares of OTLC short. 0.00% of Oncotelic Therapeutics' shares are currently sold short. Learn More on Oncotelic Therapeutics' current short interest.

What is a good short interest percentage for Oncotelic Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Oncotelic Therapeutics' floating shares are currently sold short.

Is Oncotelic Therapeutics' short interest increasing or decreasing?

Oncotelic Therapeutics saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 16 shares, a drop of 99.9% from the previous total of 15,516 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Oncotelic Therapeutics' short interest compare to its competitors?

0.00% of Oncotelic Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Oncotelic Therapeutics: OnKure Therapeutics, Inc. (0.52%), OKYO Pharma Limited Sponsored ADR (1.13%), Lifevantage Corporation (37.49%), Edesa Biotech, Inc. (3.98%), ImageneBio, Inc. (5.86%), iBio, Inc. (10.36%), Greenland Mines Ltd. Common Stock (3.33%), Cue Biopharma, Inc. (0.74%), Scilex Holding Company (1.95%), Metagenomi, Inc. (6.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short Oncotelic Therapeutics stock?

Short selling OTLC is an investing strategy that aims to generate trading profit from Oncotelic Therapeutics as its price is falling. OTLC shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oncotelic Therapeutics?

A short squeeze for Oncotelic Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OTLC, which in turn drives the price of the stock up even further.

How often is Oncotelic Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTLC, twice per month. The most recent reporting period available is April, 15 2026.

What do OTLC's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like OTLC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (OTCMKTS:OTLC) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Did you miss The Dark AI Summit?
Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...
Brownstone Research | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel